| OxideNova95 vs Jin | 22–24 | 47.83% |
| OxideNova95 vs Hwoarang | 28–16 | 63.64% |
| OxideNova95 vs Reina | 31–12 | 72.09% |
| OxideNova95 vs King | 17–23 | 42.50% |
| OxideNova95 vs Eddy | 18–15 | 54.55% |
| OxideNova95 vs Lili | 11–20 | 35.48% |
| OxideNova95 vs Azucena | 19–10 | 65.52% |
| OxideNova95 vs Law | 14–13 | 51.85% |
| OxideNova95 vs Victor | 19–8 | 70.37% |
| OxideNova95 vs Yoshimitsu | 15–11 | 57.69% |
| OxideNova95 vs Kazuya | 13–13 | 50.00% |
| OxideNova95 vs Dragunov | 9–15 | 37.50% |
| OxideNova95 vs Bryan | 15–4 | 78.95% |
| OxideNova95 vs Leroy | 11–8 | 57.89% |
| OxideNova95 vs Steve | 12–5 | 70.59% |
| OxideNova95 vs Lee | 8–8 | 50.00% |
| OxideNova95 vs Asuka | 5–10 | 33.33% |
| OxideNova95 vs Jun | 9–6 | 60.00% |
| OxideNova95 vs Xiaoyu | 7–6 | 53.85% |
| OxideNova95 vs Jack-8 | 6–6 | 50.00% |
| OxideNova95 vs Nina | 9–3 | 75.00% |
| OxideNova95 vs Devil Jin | 4–7 | 36.36% |
| OxideNova95 vs Raven | 7–4 | 63.64% |
| OxideNova95 vs Leo | 6–4 | 60.00% |
| OxideNova95 vs Paul | 4–4 | 50.00% |
| OxideNova95 vs Feng | 4–3 | 57.14% |
| OxideNova95 vs Lars | 6–0 | 100.00% |
| OxideNova95 vs Alisa | 0–6 | 0.00% |
| OxideNova95 vs Zafina | 2–4 | 33.33% |
| OxideNova95 vs Shaheen | 4–0 | 100.00% |
| OxideNova95 vs Kuma | 0–4 | 0.00% |
| OxideNova95 vs Panda | 2–2 | 50.00% |
| OxideNova95 vs Claudio | 3–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.